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It has long been accepted that acupuncture, puncturing and scraping needles at certain points on the
body, can have analgesic and anesthetic effects, as well as therapeutic effects in the treatment of vari-
ous diseases. This therapy, including acupuncture anesthesia, has drawn the attention of many inves-
tigators and become a research subject of international interest around the world. Numerous studies
have demonstrated that the nervous system, neurotransmitters, endogenous substances and Jingluo
(meridians) may respond to needling stimulation and electrical acupuncture. An abundance of infor-
mation has now accumulated concerning the neurobiological mechanisms of acupuncture, in relation
to both neural pathways and neurotransmitters/hormonal factors that mediate autonomic regulation,
pain relief and other therapeutics. Early studies demonstrated that the analgesic effects of electroacu-
puncture (EA) are mediated by opioid peptides in the periaqueductal gray. Recent evidence shows
that nitric oxide plays an important role in mediating the cardiovascular responses to EA stimulation
through the gracile nucleus-thalamic pathway. Other substances, including serotonin, catecholamines,
inorganic chemicals and amino acids such as glutamate and α-aminobutyric acid (GABA), are pro-
posed to mediate certain cardiovascular and analgesic effects of acupuncture, but at present their role
is poorly understood. The increased interest in acupuncture health care has led to an ever-growing
number of investigators pursuing research in the processes of the sense of needling touch, transduc-
tion of needling stimulation signals, stimulation parameters and placebos. In this Review, the evidence
and understanding of the neurobiological processes of acupuncture research have been summarized
with an emphasis on recent developments of nitric oxide mediating acupuncture signals through the
dorsal medulla-thalamic pathways.
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CAM Approaches to Acupuncture
Over the last few decades there has been a widespread and
increasing interest in acupuncture around the world. Investi-
gators have demonstrated that the nervous system, neuro-
transmitters and endogenous substances respond to needling
stimulation and electroacupuncture (EA) (1–3). The EA
afferent pathways and central sites have been identified in the
anterolateral tract in the spinal cord, the reticulogiganto-
cellular nucleus, the raphe magnus, the dorsal part of the
periaqueductal central gray (D-PAG), the posterior and
anterior hypothalamus and the medial part of the centro-
median nucleus of the thalamus (4–7). It has been established
that acupuncture analgesia is mediated by opioid peptides.
Recent studies have demonstrated that EA stimulation of
hindlimb acupoints induces an up-regulation of neuronal nitric
oxide synthase (nNOS)/NADPH diaphorase (NADPHd)
expression in the gracile nucleus. Nitric oxide (NO) in the
gracile nucleus mediates acupuncture signals through dorsal
medulla–thalamic pathways.
Opioidergic Mechanism in the Periaqueductal 
Central Gray
Several reports from 1977 to 1980 demonstrated that acu-
puncture analgesia is blocked or reversed by naloxone, an
opioid antagonist (8–10). It has also been shown that intra-
cerebroventricular or intrathecal injection of cholecystokinin
octapeptide (CCK-8), an endogenous opioid antagonist,
blocks analgesia induced by morphine or EA in rats (11),
indicating that an opioidergic mechanism is involved in
mediating acupuncture analgesia. These reports have shown
that naloxone reduces or abolishes the analgesia produced by42 Neurobiology of acupuncture
manual rotation of needles or low-frequency EA in human
subjects with experimental or chronic pain (12). Further-
more, naloxone reduced or abolished low-frequency EA
analgesia in various animals subjected to pain (8,10,11).
Investigators have also demonstrated that a microinjection of
naloxone into the periaqueductal gray matter and the
hypothalamus abolishes the analgesic effects of acupuncture
in animals (1,4). These studies not only confirm that low-
frequency EA analgesia is naloxone reversible, but also show
the regions of the brain involved in mediating acupuncture
analgesia.
Several studies have observed that acupuncture and trans-
cutaneous nerve stimulation has a prolonged induction and
delayed recovery period (13–15). Low frequency stimulation
of the somatic nerve also produces selective and long-lasting
depression of the vasoconstrictor components of the mid-
brain-evoked cardiovascular defense response (16). It has
been demonstrated that the antinociceptive effects induced
by EA twice in succession are markedly enhanced in the sec-
ond EA at 90 min following the first EA. The first EA effect
is opioid-mediated in the periaqueductal gray and the second
response to EA is a non-opioid effect (17). The sympatho-
inhibition and analgesia induced by low-frequency transcuta-
neous nerve stimulation is not antagonized by naloxone, an
opioid-receptor-blocking drug (14,15). The neural pathways
and neurotransmitters responsible for the non-opioid effects
of EA (the long-induction time and the long-lasting effects of
acupuncture) are unknown.
Nitric Oxide in the Dorsal Medulla–Thalamic 
Pathways
It has been demonstrated that NADPHd reactivity in the
gracile nucleus is markedly increased in intact aged rats and is
induced following sciatic nerve axotomy in young rats,
accompanied by increased number of cells showing expres-
sion of nNOS proteins and mRNA (18,19). nNOS catalyzes
the transformation of arginine to NO, which is an endo-
genous molecule produced in many cell types including neu-
rons in the brain (20,21). It has been shown that NADPHd
reactivity and nNOS immunoreactivity are increased in the
gracile nucleus induced by either unilateral electrical stimula-
tion of the sural nerve or by sciatic nerve injury (19,22).
These studies support the previous findings that the gracile
nucleus receives somatosympathetic afferent inputs and
demonstrate an increase in nNOS expression in the gracile
nucleus with an ipsilateral predominance induced by activa-
tion of afferent somatic cutaneous nerves. Furthermore, they
reported that low-frequency EA stimulation (3 Hz) applied
to the hindlimb acupuncture points (acupoints) Jinggu and
Shugu (BL 64–65), which are cutaneously located, induces
nNOS expression in the gracile nucleus (23). Although the
functional purpose for the transganglionic and/or transsyn-
aptic up-regulation of nNOS in the gracile nucleus requires
investigation, the results suggest that EA-induced nNOS-NO
in the gracile nucleus may participate in central autonomic
regulation of somatosympathetic reflex (SSR) activities,
which contribute to the therapeutic effects of acupuncture.
As illustrated in Fig. 1, the somatotopic organization of the
gracile nucleus receiving peripheral somatosensory afferents
from the hindlimb has been demonstrated with electrophysi-
ological mapping studies and anterograde axons tracing tech-
niques in various mammals (24–26). The gracile nucleus in
the dorsal medulla receives peripheral somatosensory noci-
ceptive afferents projecting from the hindlimb (25,26), and
activation of afferent cutaneous nerves results in changes in
sympathetic activity and arterial blood pressure by excitatory
SSR (27,28). It has been shown that cutaneous primary affer-
ents projecting from the hindlimb to the medulla oblongata
are distributed mainly in the gracile nucleus (24,26). The
afferent sensory fibers in the sciatic nerves originate from the
skin or muscle and the synapse is directed on dorsal horn
neurons, or on dorsal horn interneurons in the spinal cord,
which ascend to the gracile nucleus (24–26,29). Early studies
have shown that neurons in the gracile nucleus, which receive
somatosensory afferent inputs originating in nociceptors,
project to the thalamus (25,30). A number of recent studies
Figure 1. Neural circuits related to somatosympathetic reflexes in the
gracile-thalamic-cortex pathways. Axonal tracing studies show that cuta-
neous primary afferents projecting from the hindlimb to the medulla are
distributed mainly in the gracile nucleus, and synapses from the gracile
nucleus, which receive somatosensory afferent inputs project to the thalamus.
Acupuncture stimulation of hindlimb, similar to electrical stimulus to the
tibial nerve causes NO-mediated activation of somatosympathetic reflexes in
this pathway resulting in sympathoinhibition and analgesia.eCAM 2004;1(1) 43
have suggested that the gracile nucleus is an integration
center for cutaneous and visceral information flowing into
the thalamus, which plays an important role in somatic and
visceral pain processing (31–33). Electrophysiological studies
have identified that the somatosensory afferent inputs ascend
in the paraventricular thalamic nucleus (PVT), and adjacent
thalamic nuclei (34,35). The PVT with the mediodorsal
thalamic nucleus plays a role in the central autonomic con-
trol of cardiovascular and other integrative functions (36,37).
It has been reported that stimulation of afferent somatic
cutaneous or mixed nerves, such as the sural or the sciatic,
results in increased sympathetic activity and arterial blood
pressure by excitatory SSR (27,28). Early studies have sug-
gested that synaptic transmission through the dorsal column
is depressed by α-aminobutyric acid (GABA)-mediated
depolarization of the gracile afferents evoked by stimulation
of the dorsal column (38,39). Investigators have shown that
NO in the brainstem produces baroreflex-independent
inhibition of sympathetic tone and thus decreases arterial
blood pressure (40,41); NO in the brainstem possesses an
inhibitory function in the central regulation of somatocardiac
sympathetic C-reflex (42). Recent studies have shown that
L-arginine-derived NO synthesis in the gracile nucleus attenu-
ates the cardiovascular responses to stimulus-evoked excita-
tory SSR and facilitates the responses to inhibitory SSR (43).
We hypothesize that NO in the gracile nucleus plays an
inhibitory role in central cardiovascular control through SSR
regulation (Fig. 1).
Chen and Ma (44) have studied the effects of L-arginine-
derived NO synthesis in the gracile nucleus on the cardio-
vascular responses to EA stimulation of ‘Zusanli (ST36)’. EA
stimulation of ST36 produces depressor and bradycardiac
responses in rats but the same stimulation on the non-points
caused slight cardiovascular responses (44). Microinjections
of lidocaine into the gracile nucleus blocks this response,
indicating that the gracile nucleus is involved in mediating
cardiovascular responses to ST36 (Fig. 2). Moreover, micro-
injection of L-arginine into gracile nucleus facilitated the
hypotensive and bradycardiac responses to EA ST36, as
shown in Fig. 3. The cardiovascular responses to EA ST36
were attenuated by bilateral microinjection of nNOS anti-
sense oligos into gracile nucleus (Fig. 4). The results suggest
that NO plays an important role in mediating the cardio-
vascular responses to EA ST36 through gracile nucleus.
Recent results have also shown that analgesic responses to
EA ST36 are modified by L-arginine-derived NO synthesis
in the gracile nucleus (45). Extracellular neuronal activity in
the thalamus is enhanced by EA ST36, and EA ST36-
evoked activity is inhibited by the presence of NO in the grac-
ile nucleus (46). These results are consistent with previous
studies showing that the thalamic neurons receive neural
inputs from the gracile nucleus and further demonstrate that
NO in the gracile nucleus has an inhibitory function in
mediating the responses to EA ST36 by influencing the excita-
bility of the thalamic neurons. The gracile nucleus–thalamic
pathways are responsible for EA signal transduction, with
NO playing an important role in the mediation of neuronal
activities and therapeutics elicited by EA ST36.
There is growing evidence that the dorsal column pathway
(gracile nucleus) plays an important role in pain homeostasis
and nociceptive regulation (31–33). These recent reports
Figure 2. Frequency-dependent changes in mean arterial pressure (MAP,
top) and heart rate (bottom) induced by EA ST36 in anesthetized Sprague–
Dawley rats. Hypotensive and bradycardiac responses to EA stimulation of
ST36 were significantly blocked by microinjection of lidocaine into gracile
nucleus (P < 0.05, analysis of variance, n = 7/group). Parameters of stimu-
lation: 6 V, 1 ms pulse duration, 3, 10 and 30 Hz for 10 s. [Reproduced with
permission from Chen and Ma (44).]
Figure 3. Frequency–response curves for changes in mean arterial blood
pressure (MAP) in responses to EA stimulation of ST36 before and after
microinjection of L-arginine into the gracile nucleus in anesthetized rats.
Microinjection of L-arginine into the gracile nucleus enhanced the depressor
and bradycardiac responses to EA ST36 (P < 0.05, analysis of variance, n =
5/group). Other details are shown in legend to figure 2. [Reproduced with
permission from Chen and Ma (44).]44 Neurobiology of acupuncture
support the results from early studies using axonal tracing,
functional assays and electrophysiology, which have demon-
strated a somatosensory nerves–gracile nucleus–thalamic
pathway which contributes to SSR activities (24–26,29,30).
Recent studies have demonstrated that NO produces inhibi-
tory cardiovascular regulation in the brainstem (40–42), and
nNOS-NO in the gracile nucleus modifies SSR functions
while gracile nNOS is induced by sensory nerve stimulation
or lesion (18,19,43). EA stimulation of hindlimb acupoints
consistently induces nNOS expression in the gracile nucleus,
and  L-arginine-derived NO synthesis in the gracile nucleus
mediates cardiovascular responses to EA ST36 (23,44). How-
ever, systematic studies of the effects of NO in the gracile
nucleus on analgesic responses to EA stimulation of hindlimb
acupoint, including studies of other brainstem nuclei such as
the cuneate nucleus to serve as a site specificity control, are
required to evaluate the functional roles of the dorsal column
(gracile nucleus)–thalamic pathway in transduction and
modification of acupuncture signals and therapeutic effects
of acupuncture.
The Descending Pain Modulatory System
It is generally accepted that multiple supraspinal sites of the
descending pain modulatory system exert powerful effects
on the inhibitory response of the nociceptive messages at
the spinal level (47,48). The rostral ventromedial medulla
(RVM), including the nucleus raphe magnus (NRM), the
adjacent gigantocellularis pars alpha (NGCα) and ventral
nucleus reticularis gigantocellularis (NGC), plays a crucial
role in descending pain modulation (49,50). The NRM is a
major source of the descending brainstem serotoninergic
pathways and the pontine locus coeruleus/subcoeruleus (LC/
SC) sends the descending noradrenergic projections to the
spinal dorsal horn in rats (49–51). It has been demonstrated
that EA inhibited Fos expression in the dorsal horn induced
by mechanical noxious stimulation or hindlimb amputation
(52,53) and inhibited the nociceptive response (53). Recent
studies have suggested that EA-activated spinal neurons con-
vey acupuncture signals to the brain and activate a descend-
ing inhibitory system, which in turn inhibits cFos expression
in the medial area of laminae I–II in spinal cord and hyper-
algesia (54,55).
Takeshige et al. (56), demonstrated that the paragiganto-
cellular reticular nucleus in the descending adrenergic system
is elicited by acupuncture stimulation since the inhibitory
effects are antagonized by phentolamine (57). The paragi-
gantocellular reticular nucleus does not contain any nor-
adrenergic cells, therefore it must relay to a noradrenergic
structure, the LC, or some other noradrenergic lower brain-
stem neurons whose axons project into the spinal cord. These
researchers have also reported that acupuncture effects are
antagonized by methysergide (56). These results suggest that
acupuncture anesthesia descending through PAG is eventu-
ally serotonergic. Investigators have also reported that
serotonin levels are increased in mast cells and platelets
following acupuncture (58,59). These latter reports might
be considered an explanation of the long lasting effects of
acupuncture in addition to direct synaptic inhibition.
EA Stimulation Parameters and Placebos
Electrical stimulation has been widely used in acupuncture
research on animal models and humans because it can be
controlled and quantified easily, and thus it is repeatable.
The effect of EA depends on stimulation parameters, which
include intensity, frequency, pulse widths (duration) and time
table.
Figure 4. Time response histogram of antisense oligos to nNOS in the
gracile nucleus on the cardiovascular responses caused by EA ST36 in rats.
The depressor (top) and bradycardiac responses (bottom) were inhibited by
microinjection of nNOS antisense oligos into the gracile nucleus (P < 0.05,
analysis of variance, n = 5/group). The inhibiting effects began at 30 min
after injection, and the maximum effects occurred at 45 min. The effects
reversed at 90 min after the injection. Microinjection of nNOS sense oligos
into the gracile nucleus did not alter the responses to stimulation of ST36.
Other details are shown in legend to figure 2. [Reproduced with permission
from Chen and Ma (44).]eCAM 2004;1(1) 45
Identified Primary Afferents by Using Different EA 
Intensity
The spatial organization of the central terminals of primary
afferents are located in the dorsal horn: the low-threshold
Aα/Aβ mechanoreceptors are distributed longitudinally in
laminae III–V; the high-threshold C fibers terminate longitu-
dinally in laminae I and II; and Aδ mechanoreceptors termi-
nate in laminae I and V (60,61). Examination of compound
action potentials in rats shows that a stimulus of 0.1 mA is
sufficient for producing an Aα/Aβ wave in the dorsal root,
but not Aδ wave, which requires at least 0.2 mA. Production
of a C wave requires at least 1 mA (62). It is generally
accepted that acupuncture/EA activates deep receptors (63),
and EA-evoked effects appear to be manifested via activation
of small-diameter, high-threshold primary sensory afferents,
possibly C fibers (64,65). EA-induced activation of large-
diameter primary afferents alone produces analgesic and
antinociceptive effects (66–69).
Stimulation Frequency
Low frequency stimulation of acupuncture points produces
arterial blood depression and analgesia in rats (13,17).
Effects of low frequency EA are likely processed in the higher
center, while high frequency EA effects are most likely
located between supraspinal and the lower brainstem (4,
70–72). Low frequency EA activates beta-endorphin and
enkephalin systems, while high frequency EA activates
dynorphin systems (73). More recent studies have shown that
high (100 Hz) and low (10 Hz) EA frequencies may induce
similar antihyperalgesic effects (74).
Pulse Widths (Duration) and Time Table
Durations of 1.0 ms are frequently used in EA treatment in
both animal studies and clinical observations. Recent studies
suggest that higher EA current intensity is more effective
than wider EA pulse width in enhancing antihyperalgesia at a
given frequency (74). Acupuncture has a prolonged induction
and a delayed recovery period (13,17). The antinociceptive
effects induced by EA twice in succession are markedly
enhanced in the second EA at 90 min following the first EA
(17). Thus, 20–30 min EA is the best stimulation period; two
phases stimulation is better than single stimulation and a
longer EA treatment may not necessarily correlate with a
better therapeutic effect.
Placebo Effects and Sham Acupuncture
To evaluate specific effects, choosing an appropriate control
is an important issue in acupuncture research. Controls
applied in acupuncture research include placebo, sham acu-
puncture, needling superficially, needling wrong or inade-
quate points, etc. In the most commonly used control
treatments, needling is carried out at theoretically irrelevant
sites, away from the classical acupoint locations, called ‘non-
acupoints’. Depth of insertion and stimulation are the same,
with the needle inserted close to acupoints and related
meridian lines, but in an area that does not contain acu-
points or meridian lines. This procedure, which is termed
‘non-acupoints’ or ‘sham’ acupuncture, has been used as a
placebo in many studies (75–77). This method was initially
assumed by most investigators to be ineffective, and therefore
ideal for use as a control or placebo. However, many studies
found that this control has some of the same effects as real
acupuncture (75,77–81). It is clear that this control only
offers information about the most effective sites of needling,
not about the specific effects of acupuncture (82).
Investigators have recently designed a sham acupuncture
needle (the Park Sham Needle) which does not puncture the
skin, but appears to do so from the point of view of the naive
patient (83). The apparatus consists of a blunted needle, with
a shaft that telescopes into the handle when applied to the
surface of the skin. Although the needle appears to have been
inserted, it does not actually pierce the skin. In testing the
efficacy of the sham acupuncture device, research has found
that the procedure using the new device is indistinguishable
from the same procedure using real needles in acupuncture
(84). Similar to the Park Sham Needle, the Placebo Needle
was designed to simulate the acupuncture needling procedure
without puncturing the skin (85). In testing this new device,
results demonstrated that, of 60 volunteers, 54 felt a penetra-
tion with acupuncture and 47 felt it with the placebo needle.
As the major focus on the specific effects of acupuncture,
minimal acupuncture has been used as a control condition in
several studies to minimize the specific effects of the nee-
dling, while maintaining the psychological impact since it is
very similar to real treatment. It is possible that minimal
acupuncture might have a small therapeutic effect but it is
slightly more difficult to demonstrate a difference between
treatment and control (82). In some sham-treated controls,
the needle electrode is placed into the same acupoints with
the same depth of insertion but without performing the stim-
ulation. A needle taped on the surface of the acupoint is also
used to serve as a placebo control. There is some evidence to
show that certain types of acupuncture ‘placebos’ may have
effects (86). It appears that evidence for the effectiveness of
placebo is inadequate, and somewhat controversial.
Conclusion
The utilization of acupuncture and EA therapies is high and
on the rise in Western societies. Acupuncture involves stimu-
lating specific anatomic points along the body by puncturing
the skin with a needle; practitioners may also use heat, pres-
sure or impulses of electrical energy to stimulate the points.
Investigators have demonstrated that the nervous system,
neurotransmitters and endogenous substances respond to
needling stimulation and EA (1–3). The EA afferent path-
ways and central sites have been identified in the antero-
lateral tract in the spinal cord, the reticulogigantocellular
nucleus, the raphe magnus, the dorsal part of the periaque-46 Neurobiology of acupuncture
ductal central gray, the posterior and anterior hypothalamus,
the medial part of the centromedian nucleus of the thalamus,
and the dorsal medullar-thalamic pathways (4–8,23,44–46).
Prior studies have established that acupuncture analgesia is
mediated by opioid peptides (8–12). Recent evidence has
demonstrated that L-arginine-derived NO in the gracile
nucleus contributes to neuronal responses to EA hindlimb
acupoints through the dorsal medullar–thalamic neuronal
pathway (23,44–46). Other substances, including serotonin,
catecholamines, inorganic chemicals and amino acids such as
glutamate and GABA, may also mediate some of the cardio-
vascular and analgesic effects of acupuncture, but at present
their role is little understood (1–3). In spite of experiments
documenting a biological basis of acupuncture analgesia and
the increasing use of acupuncture for a number of pain condi-
tions, systematic research of EA manipulation and stimula-
tion has not been conducted. Only further evidence of the
neurobiology mechanisms and effectiveness of acupuncture
research will answer these questions.
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